Gino-medevar suppositories vaginal 150mg N3
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Econazole
Release form
Suppositories
Composition
Active ingredient: Econazole Concentration of active ingredient (mg): 150 mg
Pharmacological effect
Antifungal agent for local and external use. is a derivative of imidazole. possesses a wide range of antifungal action. active against trichophyton rubrum, trichophyton tonsurans, microsporum canis, epidermophyton floccosum, candida albicans, and some gram-positive bacteria.
Pharmacokinetics
When applied to the skin, systemic absorption is minimal and practically insignificant. Therapeutic concentrations are created in the epidermis (including in the stratum corneum), as well as in the dermis. Less than 1% of the applied dose is excreted with feces and kidneys.
Indications
Gyno-Pevaril is indicated for the treatment of vulvovaginal mycoses.
Contraindications
Hypersensitivity to any of the components of the drug. Children under 16 years of age. With caution Data on the use of Gyno-Pevaril in the elderly (over 65) are insufficient.
Precautionary measures
Keep out of the reach of children.
Use during pregnancy and lactation
Use during pregnancy is possible only when the intended benefit to the mother outweighs the potential risk to the fetus. In the period of lactation is used with caution.
Dosage and administration
Intravaginally. Suppositories of 50 mg Vaginal suppository is injected deep into the vagina, in the supine position, immediately before going to bed for at least 14 days. It is necessary to conduct a full course of treatment, despite the disappearance of subjective symptoms (itching, bleaching). Suppositories of 150 mg Vaginal suppository is injected deep into the vagina, in the supine position, immediately before going to bed for 3 days. In the case of a relapse or a positive result of a culture study, a second course of treatment is performed 1 week after the treatment.
Side effects
When applying Gyno-Pevara, there may be local irritation, burning sensation, itching, erythema, rash. There are isolated cases of allergic reactions, such as angioedema and urticaria. Side effects of the drug are systematized according to the organs and frequency of occurrence using the following classification: very often (more than 1/10), often (more than 1/100, less than 1/10), infrequently (more than 1/1000, less than 1/100), rarely (more than 1/10000 less than 1/1000), very rarely (less than 1 / 10,000), including isolated cases. On the part of the immune system: Very rare: hypersensitivity.On the part of the skin and subcutaneous tissues: Very rare: angioedema, urticaria, contact dermatitis, peeling of the skin, erythema. General disorders and reactions at the injection site: Very rarely: pain, irritation and swelling at the injection site.
Overdose
Cases of overdose are not registered.
special instructions
Use during pregnancy is possible only when the intended benefit to the mother outweighs the potential risk to the fetus. During lactation is used with caution. You should avoid contact with econazole in the eye.